3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Colorectal Neoplasms
21
Carcinoma, Renal Cell
3
Carcinoma, Non-Small-Cell Lung
3
Uterine Cervical Neoplasms
2
Stomach Neoplasms
2
Squamous Cell Carcinoma of Head and Neck
2
Ovarian Neoplasms
2
Neoplasm Metastasis
2
Melanoma
2
Lung Neoplasms
2
Colonic Neoplasms
2
Carcinoma, Neuroendocrine
2
Brain Neoplasms
2
Urinary Bladder Neoplasms
1
Triple Negative Breast Neoplasms
1
Thyroid Neoplasms
1
Solid Tumors
1
Small Cell Lung Carcinoma
1
Ras-mutated Metastatic Colorectal Cancer
1
Prostatic Neoplasms
1
Pancreatic Neoplasms
1
Pancreatic Adenocarcinoma Metastatic
1
Neoplasms
1
Kidney Neoplasms
1
Histiocytosis
1
Head and Neck Neoplasms
1
Glioblastoma
1
Gastrointestinal Neoplasms
1
Gastroesophageal Adenocarcinoma
1
Esophageal Squamous Cell Carcinoma
1
Interventions
regorafenib
2
ivosidenib
2
Proton Therapy
2
enasidenib
1
durvalumab
1
capivasertib
1
abemaciclib
1
Zoledronic Acid
1
Weight-Bearing
1
Taxes
1
Surveys and Questionnaires
1
Standard of Care
1
Range of Motion, Articular
1
Pharmacogenomic Testing
1
Paclitaxel
1
Immunoglobulin G
1
HhAntag691
1
Gemcitabine
1
Disulfides
1
Cisplatin
1
Bevacizumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Chondrosarcoma
×
IFL protocol
×
1 year
×
Clear all
No trials found.